M K Proteins

Which are the latest news on M K Proteins?

Why is M K Proteins Ltd falling/rising?

As of 05-Sep, M K Proteins Ltd's stock price is at 4.03, reflecting a year-to-date decline of 33.93% and a one-year drop of 39.49%. The stock is underperforming with negative returns over the last three years, declining investor participation, and significant drops in profits, indicating a lack of confidence in its long-term growth prospects.

As of 05-Sep, M K Proteins Ltd's stock price is falling, currently at 4.03, which reflects a decrease of 0.05 or 1.23%. The stock has underperformed significantly over various time frames, with a year-to-date decline of 33.93% and a one-year drop of 39.49%. This consistent underperformance is highlighted by the fact that the stock has generated negative returns in each of the last three annual periods compared to the benchmark BSE500.<BR><BR>Today's performance indicates that the stock is trading lower than its moving averages across all time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, there has been a notable decline in investor participation, with delivery volume falling by 59.03% against the 5-day average. The sector itself, Solvent Extraction, has also experienced a decline of 2.26%, which may contribute to the negative sentiment surrounding M K Proteins.<BR><BR>Despite being net-debt free and having an attractive valuation with a price-to-book value of 2.1, the company's operating profit has suffered a significant annual decline of 29.20% over the last five years. Furthermore, the latest financial results show a substantial drop in profits, with a 60.06% decrease in profit after tax over the last six months. These factors collectively indicate a lack of confidence in the company's long-term growth prospects, leading to the current downward trend in its stock price.

Who are in the management team of M K Proteins?

The management team of M K Proteins includes Vinod Kumar (Chairman & Managing Director), Raj Kumar (Whole-time Director), Parvind Kumar, Pramod Kumar (Directors), and several Independent Directors: Chatter Singh, Raman Kumar Sah, Abhay Kumar, Dinesh Singh Malik, and Laxmi Mandal, along with Prerna Mehta as Company Secretary & Compliance Officer.

The management team of M K Proteins includes the following individuals:<BR><BR>1. **Vinod Kumar** - Chairman & Managing Director<BR>2. **Raj Kumar** - Whole-time Director<BR>3. **Parvind Kumar** - Director<BR>4. **Pramod Kumar** - Director<BR>5. **Chatter Singh** - Independent Director<BR>6. **Raman Kumar Sah** - Independent Director<BR>7. **Abhay Kumar** - Independent Director<BR>8. **Dinesh Singh Malik** - Independent Director<BR>9. **Laxmi Mandal** - Independent Director<BR>10. **Prerna Mehta** - Company Secretary & Compliance Officer<BR><BR>If you have any more questions about M K Proteins or its operations, feel free to ask!

What does M K Proteins do?

M K Proteins Ltd is a Micro Cap company in the Edible Oil industry, incorporated in 2012 and publicly listed since 2017, with recent quarterly net sales of 115 Cr and a net profit of 1 Cr as of June 2026. The company has a market cap of INR 153 Cr and key financial metrics include a P/E ratio of 33.00 and a return on equity of 6.37%.

Overview:<BR>M K Proteins Ltd operates in the Edible Oil industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>The company was incorporated in 2012 as "M K Proteins Private Limited" in Haryana and later converted to a Public Limited Company, changing its name to "M K Proteins Limited" in 2017. The latest quarterly results reported net sales and profit for June 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 115 Cr (Quarterly Results - Jun 2026)<BR>- Net Profit: 1 Cr (Quarterly Results - Jun 2026)<BR>- Market cap: INR 153 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 33.00<BR>- Industry P/E: 26<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -0.03<BR>- Return on Equity: 6.37%<BR>- Price to Book: 2.10<BR><BR>Contact Details:<BR>Address: Naraingarh Road, Village Garnala Ambala Haryana : 134003<BR>Tel: 91-171-2679157/2679358<BR>Email: info@mkproteins.in<BR>Website: http://www.mkproteins.in

Who are the peers of the M K Proteins?

M K Proteins' peers include Evexia Lifecare, Integ. Proteins, Vijay Solvex, Ajanta Soya, Sarda Proteins, Ramdevbaba Sol., and Rajgor Castor. Management risk is average for M K Proteins and several peers, with Rajgor Castor showing excellent growth and capital structure, while M K Proteins has a 1-year return of -36.50%.

Peers: The peers of M K Proteins are Evexia Lifecare, Integ. Proteins, Vijay Solvex, Ajanta Soya, Sarda Proteins, Ramdevbaba Sol., and Rajgor Castor.<BR><BR>Quality Snapshot: Excellent management risk is observed at Rajgor Castor, while Average management risk is found at M K Proteins, Evexia Lifecare, and Ajanta Soya, and the rest have Below Average management risk. Growth is Excellent at Rajgor Castor, Average at Integ. Proteins, and Below Average at M K Proteins, Vijay Solvex, Ajanta Soya, Sarda Proteins, Ramdevbaba Sol., and the rest. For Capital Structure, Excellent is noted at Vijay Solvex and Ajanta Soya, Good at Integ. Proteins and Sarda Proteins, while M K Proteins has Excellent, and the rest have Below Average.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Integ. Proteins with N/A, while the lowest is Evexia Lifecare at -35.40%, and M K Proteins has a 1-year return of -36.50%, which is lower than Evexia Lifecare. Additionally, peers with negative six-month returns include Evexia Lifecare, Vijay Solvex, M K Proteins, Sarda Proteins, and Ramdevbaba Sol.

How big is M K Proteins?

As of 31st August, M K Proteins Ltd has a market capitalization of 153.00 Cr, with recent net sales of 383.09 Cr and a net profit of 4.70 Cr. The latest balance sheet shows shareholder's funds of 69.47 Cr and total assets of 130.23 Cr.

As of 31st August, M K Proteins Ltd has a market capitalization of 153.00 Cr, classified as a Micro Cap company.<BR><BR>In the latest four quarters, M K Proteins reported Net Sales of 383.09 Cr and a Net Profit of 4.70 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, showing Shareholder's Funds of 69.47 Cr and Total Assets of 130.23 Cr.

Should I buy, sell or hold M K Proteins Ltd?

When is the next results date for M K Proteins Ltd?

The next results date for M K Proteins Ltd is 13 August 2026.

The next results date for M K Proteins Ltd is scheduled for 13 August 2026.

Are M K Proteins Ltd latest results good or bad?

M K Proteins Ltd's latest results are concerning, as revenue increased by 62.95% to ₹145.94 crores, but net profit fell by 59.29% to ₹1.14 crores, indicating significant margin compression and operational challenges despite record revenue.

The latest results for M K Proteins Ltd indicate a challenging situation for the company. While the revenue for Q4 FY26 showed a significant increase of 62.95% quarter-on-quarter, reaching ₹145.94 crores, the net profit plummeted by 59.29% both quarter-on-quarter and year-on-year, down to ₹1.14 crores. This stark contrast highlights a troubling disconnect between revenue growth and profitability.<BR><BR>The operating margin also fell sharply to 1.71%, down from 2.65% in the previous quarter, marking a significant decline in operational efficiency. Additionally, the PAT margin dropped to 0.78%, the lowest in several quarters. This suggests that the company is facing severe margin compression, likely due to rising costs and competitive pressures in the edible oil sector.<BR><BR>Overall, despite achieving record revenue, the substantial drop in profitability and margins indicates that the results are more concerning than positive. Investors may view these developments as a signal of underlying operational challenges that need to be addressed for future growth and stability.

How has been the historical performance of M K Proteins?

M K Proteins' historical performance shows fluctuating revenue, with net sales increasing to 267.71 Cr in March 2025 from 245.57 Cr in March 2024, but declining from 314.86 Cr in March 2023. Profitability decreased, with operating profit falling to 12.43 Cr and cash flow showing a negative trend, indicating challenges in profitability and cash management despite some sales growth.

Answer:<BR>The historical performance of M K Proteins shows fluctuations in key financial metrics over the years, with notable changes in revenue and profitability.<BR><BR>Breakdown:<BR>M K Proteins reported net sales of 267.71 Cr in March 2025, an increase from 245.57 Cr in March 2024, but a decline from 314.86 Cr in March 2023. The total operating income followed a similar trend, reaching 267.71 Cr in March 2025 compared to 245.57 Cr in the previous year. The company's total expenditure, excluding depreciation, was 255.28 Cr in March 2025, up from 228.95 Cr in March 2024. Operating profit, excluding other income, decreased to 12.43 Cr in March 2025 from 16.62 Cr in March 2024, leading to an operating profit margin of 4.64%. Profit before tax also declined to 11.45 Cr in March 2025 from 15.47 Cr in March 2024, resulting in a profit after tax of 8.40 Cr. The company's total assets increased to 130.23 Cr in March 2025 from 95.87 Cr in March 2024, while total liabilities rose to 130.23 Cr from 95.87 Cr in the same period. Cash flow from operating activities showed a negative trend, with a cash outflow of 16.00 Cr in March 2025, contrasting with a positive inflow of 32.00 Cr in March 2024. Overall, M K Proteins experienced a mixed performance with some growth in sales but challenges in profitability and cash flow management.

Is M K Proteins overvalued or undervalued?

As of November 19, 2025, M K Proteins is considered very attractive and undervalued, with a PE ratio of 28.91, an EV to EBITDA of 18.57, and a ROCE of 17.66%, making it a compelling investment opportunity despite a year-to-date return of -20.34%.

As of 19 November 2025, the valuation grade for M K Proteins has moved from attractive to very attractive, indicating a positive shift in its perceived value. The company is currently assessed as undervalued. Key ratios include a PE ratio of 28.91, an EV to EBITDA of 18.57, and a ROCE of 17.66%. <BR><BR>In comparison to its peers, M K Proteins has a significantly lower PE ratio than Manorama Industries, which stands at 45.44, and a more favorable EV to EBITDA ratio than CIAN Agro, which is at 16.34. Despite recent underperformance, with a year-to-date return of -20.34% compared to the Sensex's 9.02%, the strong valuation metrics suggest that M K Proteins presents a compelling investment opportunity.

Who are the top shareholders of the M K Proteins?

The top shareholders of M K Proteins are primarily promoters, with Pragun Garg holding the largest individual stake at 6.33%. Individual investors collectively own 21.6% of the shares, and there are no pledged promoter holdings or investments from mutual funds or foreign institutional investors.

The top shareholders of M K Proteins primarily consist of the promoters, with Pragun Garg holding the highest individual stake at 6.33%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. Additionally, individual investors collectively hold 21.6% of the company's shares.

What is the technical trend for M K Proteins?

As of May 12, 2025, M K Proteins shows a mildly bearish trend overall, with mixed signals from various indicators, including a mildly bullish weekly MACD and Bollinger Bands, but daily moving averages indicating caution.

As of 12 May 2025, the technical trend for M K Proteins has changed from bearish to mildly bearish. The weekly MACD is mildly bullish, while the daily moving averages indicate a mildly bearish stance. The Bollinger Bands on the weekly chart are also mildly bullish, contrasting with the monthly view which is bearish. The KST shows a mildly bullish trend on the weekly timeframe, and Dow Theory supports a mildly bullish outlook as well. However, the overall sentiment remains cautious due to the daily moving averages and the lack of strong signals from the RSI and OBV. The current technical stance is mildly bearish, reflecting mixed signals across different indicators.

What is the bonus history of the M K Proteins?

M K Proteins has a history of issuing bonuses, with the latest being a 2:1 bonus announced for March 15, 2024, following another 2:1 bonus on February 3, 2023. This demonstrates the company's commitment to rewarding its shareholders.

M K Proteins has a history of issuing bonuses, with the most recent being a 2:1 bonus issue announced for March 15, 2024. Prior to that, the company also issued a 2:1 bonus on February 3, 2023. This consistent approach to bonus issues reflects the company's strategy to reward its shareholders. If you have any more questions about M K Proteins or need further details, feel free to ask!

Has M K Proteins declared dividend?

No Dividend History Available